Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
|Slideshows|January 7, 2020
Top 5 obstetric studies from December 2019
Author(s)Judith M. Orvos, ELS, Ben Schwartz
From disability and miscarriage risk to diets during pregnancy, these are Contemporary OB/GYN's selections for five of the most noteworthy obstetric studies that were published in December 2019.
Advertisement
Advertisement
Related to this article
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG guideline expands menopause VMS, sleep, and mood recommendations
2
Countering COVID-19 vaccine myths in pregnancy
3
Psychotherapy in menopause care: Addressing fear, anxiety, and GSM
4
Organon reports interim phase 3 data for MIUDELLA IUD through 6 years
5